Teladoc Health (NYSE:TDOC) Hits New 12-Month Low at $9.52

Shares of Teladoc Health, Inc. (NYSE:TDOC) hit a new 52-week low during mid-day trading on Monday . The company traded as low as $9.52 and last traded at $9.53, with a volume of 1888057 shares. The stock had previously closed at $9.78.

Analysts Set New Price Targets

A number of research analysts recently weighed in on TDOC shares. Needham & Company LLC reaffirmed a “hold” rating on shares of Teladoc Health in a research note on Friday, April 26th. TD Cowen decreased their price target on shares of Teladoc Health from $16.00 to $15.00 and set a “hold” rating on the stock in a research note on Friday, April 26th. JPMorgan Chase & Co. decreased their price target on shares of Teladoc Health from $19.00 to $16.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 21st. Truist Financial decreased their price target on shares of Teladoc Health from $23.00 to $17.00 and set a “hold” rating on the stock in a research note on Wednesday, March 6th. Finally, Bank of America cut their price objective on shares of Teladoc Health from $16.50 to $13.50 and set a “neutral” rating for the company in a report on Tuesday, May 14th. Thirteen research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average price target of $18.22.

Teladoc Health Stock Performance

The company’s 50 day simple moving average is $11.57 and its 200 day simple moving average is $15.72. The stock has a market cap of $1.60 billion, a price-to-earnings ratio of -6.68 and a beta of 0.99. The company has a debt-to-equity ratio of 0.67, a quick ratio of 3.74 and a current ratio of 3.82.

Teladoc Health (NYSE:TDOC) last announced its earnings results on Thursday, April 25th. The health services provider reported ($0.49) EPS for the quarter, missing the consensus estimate of ($0.47) by ($0.02). The firm had revenue of $646.13 million during the quarter, compared to analyst estimates of $637.31 million. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.90%. The business’s quarterly revenue was up 2.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned ($0.37) earnings per share. On average, equities research analysts anticipate that Teladoc Health, Inc. will post -1.05 earnings per share for the current year.

Insider Transactions at Teladoc Health

In related news, COO Michael Willem Waters sold 5,793 shares of the firm’s stock in a transaction on Thursday, May 2nd. The stock was sold at an average price of $12.69, for a total value of $73,513.17. Following the completion of the transaction, the chief operating officer now directly owns 64,881 shares of the company’s stock, valued at $823,339.89. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other Teladoc Health news, insider Laizer Kornwasser sold 10,411 shares of the firm’s stock in a transaction dated Thursday, May 2nd. The stock was sold at an average price of $12.69, for a total transaction of $132,115.59. Following the transaction, the insider now owns 86,070 shares in the company, valued at $1,092,228.30. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, COO Michael Willem Waters sold 5,793 shares of Teladoc Health stock in a transaction dated Thursday, May 2nd. The shares were sold at an average price of $12.69, for a total value of $73,513.17. Following the transaction, the chief operating officer now owns 64,881 shares in the company, valued at approximately $823,339.89. The disclosure for this sale can be found here. Over the last three months, insiders sold 32,150 shares of company stock worth $392,913. 0.95% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in TDOC. Vanguard Group Inc. lifted its position in shares of Teladoc Health by 11.8% during the 4th quarter. Vanguard Group Inc. now owns 17,515,127 shares of the health services provider’s stock valued at $377,451,000 after acquiring an additional 1,855,480 shares during the period. ARK Investment Management LLC lifted its position in shares of Teladoc Health by 4.5% during the 4th quarter. ARK Investment Management LLC now owns 21,224,565 shares of the health services provider’s stock worth $457,389,000 after buying an additional 912,692 shares during the last quarter. Dimensional Fund Advisors LP lifted its position in shares of Teladoc Health by 25.0% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,834,422 shares of the health services provider’s stock worth $82,636,000 after buying an additional 767,999 shares during the last quarter. Norges Bank acquired a new stake in shares of Teladoc Health in the fourth quarter valued at about $9,714,000. Finally, Pale Fire Capital SE acquired a new stake in shares of Teladoc Health in the fourth quarter valued at about $8,960,000. Institutional investors and hedge funds own 76.82% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.